Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Strasser-Weippl

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|February 12, 2014
Ferritin as prognostic marker in multiple myeloma patients undergoing autologous transplantationKathrin Strasser-Weippl, Heinz Ludwig
Onkologie|June 29, 2007
A survey among oncologists on measures needed to improve cancer careKathrin Strasser-Weippl, Heinz Ludwig
European Journal of Haematology|July 19, 2008
Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myelomaKathrin Strasser-Weippl, Heinz Ludwig
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Prevention strategies with aromatase inhibitorsPaul E Goss, Kathrin Strasser-Weippl
Best Practice & Research. Clinical Endocrinology & Metabolism|December 23, 2003
Aromatase inhibitors for chemopreventionPaul E Goss, Kathrin Strasser-Weippl
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Competing risks in low-risk breast cancerKathrin Strasser-Weippl, Paul E Goss
Nature Reviews. Clinical Oncology|October 9, 2013
Suitable trial designs and cohorts for preventive breast cancer agentsKathrin Strasser-Weippl, Paul E Goss
Breast Care (Basel, Switzerland)|March 19, 2016
Current Status and Future Projections of Breast Cancer in AsiaLei Fan, Paul E Goss, Kathrin Strasser-Weippl
Cancer|October 13, 2015
Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A reviewDenise Froes Brandao, Kathrin Strasser-Weippl, Paul E Goss
BMC Cancer|February 3, 2007
Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat modelPaul E Goss, Kathrin Strasser-Weippl, Shangle Qi, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|February 12, 2014
Ferritin as prognostic marker in multiple myeloma patients undergoing autologous transplantationKathrin Strasser-Weippl, Heinz Ludwig
Onkologie|June 29, 2007
A survey among oncologists on measures needed to improve cancer careKathrin Strasser-Weippl, Heinz Ludwig
European Journal of Haematology|July 19, 2008
Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myelomaKathrin Strasser-Weippl, Heinz Ludwig
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Prevention strategies with aromatase inhibitorsPaul E Goss, Kathrin Strasser-Weippl
Best Practice & Research. Clinical Endocrinology & Metabolism|December 23, 2003
Aromatase inhibitors for chemopreventionPaul E Goss, Kathrin Strasser-Weippl
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Competing risks in low-risk breast cancerKathrin Strasser-Weippl, Paul E Goss
Nature Reviews. Clinical Oncology|October 9, 2013
Suitable trial designs and cohorts for preventive breast cancer agentsKathrin Strasser-Weippl, Paul E Goss
Breast Care (Basel, Switzerland)|March 19, 2016
Current Status and Future Projections of Breast Cancer in AsiaLei Fan, Paul E Goss, Kathrin Strasser-Weippl
Cancer|October 13, 2015
Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A reviewDenise Froes Brandao, Kathrin Strasser-Weippl, Paul E Goss
BMC Cancer|February 3, 2007
Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat modelPaul E Goss, Kathrin Strasser-Weippl, Shangle Qi, et al.
Pageof 4